GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Bruce SF, Cho K, Noia H, Lomonosova E, Stock E, Oplt A, Blachut B, Mullen MM, Kuroki LM, Hagemann AR, McCourt CK, Thaker PH, Khabele D, Powell MA, Mutch DG, Shriver LP, Patti GJ, and Fuh KC
Molecular Cancer Therapeutics, 21(8), 1348-1359, 2022